EZH2 and hepatocellular carcinoma: A concentration gradient of DZNep (an inhibitor of all S­adenosyl­methionine (SAM)­dependent enzymes, including EZH2) [37] and GSK126 (a selective inhibitor of EZH2 methyltransferase activity) [38] were applied to reprogram the epigenetic pathways in hepatoma cells.